NDC properties for "dabigatran etexilate 30 MG (as dabigatran etexilate mesylate 34.59 MG) Oral Pellet" (RxCUI 2590627)
About this data
The tables show NDC propoerties for dabigatran etexilate 30 MG (as dabigatran etexilate mesylate 34.59 MG) Oral Pellet with the RxCUI 2590627
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for dabigatran etexilate 30 MG (as dabigatran etexilate mesylate 34.59 MG) Oral Pellet (RxCUI 2590627)
| MMSL_CODE | CD39052 |
|---|---|
| RxCUI | 2590627 |
| VUID | 4042038 |
| Prescribable Synonym | dabigatran etexilate 30 MG Oral Pellet |
| RXNAV_STR | dabigatran etexilate 30 MG Oral Pellet |
| RxNorm Name | dabigatran etexilate 30 MG Oral Pellet |
| RxNorm Synonym | dabigatran etexilate 30 MG (as dabigatran etexilate mesylate 34.59 MG) Oral Pellet |
| Related queries | Interactions (for RxCUI 2590627) |
NDC Properties
no results for this query in NIH